NET PROFIT (x1000 EUR)
EMPLOYEES
Evaxion Biotech A/S
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | -21,572 | -13,901 | -2 |
Total assets | 35,369 | 9,476 | 1 |
Current assets | 29,935 | 8,074 | 1 |
Current liabilities | 3,746 | 3,747 | 0 |
Equity capital | 28,619 | 5,728 | 1 |
- share capital | 3,120 | 121 | 0 |
Employees (average) | 35 | 35 | 35 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 80.9% | 60.4% | 100% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 799.1% | 215.5% | |
Return on equity (ROE) | -75.4% | -242.7% | -200% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | 20 |
Chg. No. of employees % | 0% | 0% | 133% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.